According to a recent market analysis conducted by Future Market Insights, the global molluscum contagiosum (MC) treatment market is on the brink of significant expansion over the coming decade. The market, valued at an estimated USD 3 billion in 2023, is anticipated to grow at a compound annual growth rate (CAGR) of 5%, potentially reaching an impressive USD 4.89 billion by 2033.
This projected surge in market value is underpinned by a multitude of factors. Firstly, there has been a noticeable uptick in the prevalence of Molluscum Contagiosum on a global scale. Coupled with this rise is an increased awareness and higher rates of diagnosis, contributing to heightened demand for effective treatment solutions.
Moreover, advancements in medical treatments are revolutionizing the landscape of MC treatment options, providing patients with more efficacious and accessible avenues for managing the condition. This, combined with substantial healthcare spending dedicated to combatting infectious diseases, further propels the market forward.
The anticipated growth of the global MC treatment market signifies a promising trajectory for both healthcare providers and patients alike. With innovative solutions on the horizon and a growing commitment to addressing infectious diseases, the future looks brighter than ever for those affected by Molluscum Contagiosum.
Key Takeaways from the Market Study:
- From 2018 to 2022, the Molluscum Contagiosum (MC) Treatment market grew at a CAGR of 3.5%.
- The global Molluscum Contagiosum (MC) Treatment market is expected to grow with a 5% CAGR during 2023 to 2033.
- As of 2033, the Molluscum Contagiosum (MC) Treatment Market is expected to reach USD 4.89 Billion.
- According to the FMI analysis, surgical treatment accounts for the largest market share.
- North America is expected to possess 40% market share for the Molluscum Contagiosum (MC) Treatment market.
- The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.
“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Molluscum Contagiosum (MC) Treatment.” says an FMI analyst
Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!
Market Competition:
Key players in the market include companies such as Competition Deep Dive, Novan, Inc., Veloce Biopharma, Gurina Foundation, Azafaros, Polaryx Therapeutics, Abbott Medtronic, Merck & Co., Inc., Pfizer Inc., Siemens Healthcare GmbH, Novartis AG, along with healthcare providers and technology companies among other global players.
- In January 2023, Novan, Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for berdazimer gel, 10.3% (SB206) for the treatment of molluscum contagiosum. The filing is expected to be reviewed within a typical 12-month period, with a potential approval date in the first quarter of 2024 if accepted. Results from the pivotal Phase 3 B-SIMPLE4 clinical study evaluating berdazimer gel, 10.3% were highly statistically significant and demonstrated improvement in primary clinical endpoint, and the product was found to be well tolerated with mild adverse events reported.
Key Segments Profiled in the Molluscum Contagiosum (MC) Treatment Industry Survey:
Therapy:
- Cryotherapy
- Curettage
- Immune-modulating Therapies
- Topical Therapies
End-User:
- Hospital
- Skin Clinics
- Immunocompromised Patients
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
